cystinosisrn – Page 9 – Cystinosis Research Network

Recordati Announces Availability of CYSTADROPS in the U.S.

Beginning September 15, 2020, Recordati Rare Diseases announced the availability of CYSTADROPS across the United States. CYSTADROPS are a...

To address the shortage of Cystaran eye drops some members of our community may have encountered recently, Leadient Biosciences...

Recordati announced approval of an eye drop treatment to reduce corneal crystals. “We are pleased to bring Cystadrops® to...

We are going virtual! The CRN is introducing a series of virtual meetups taking place this fall. Available to...

Partnering with RDMD, this program aims to accelerate cystinosis research to ultimately improve treatment options. We welcome you to...

We are pleased to announce a collaboration between the Cystinosis Research Network (CRN) and Cystinosis Ireland to fund a...

AVROBIO announces the second patient with cystinosis has been dosed in the company’s AVR-RD-04 investigational gene therapy Phase 1/2...

On Thursday, July 2nd, the CRN announced a face mask fundraiser to help create awareness, bring in donations and...

In the third episode of “Cystinosis Sessions,” a live video conference series created by adults living with cystinosis, topics...

The Rare Diseases Clinical Research Network (RDCRN) is hoping to learn how the COVID-19 pandemic impacts people who live...